Word: dulling
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...well-cologned manager Bill Cayton against the understated promoter Don King. Last August, once Tyson had all the belts, King threw a coronation for history's youngest heavyweight champion. The melancholy scene recalled King Kong crusted with what the promoter called "baubles, rubies and fabulous other doodads." Beholding the dull eyes and meek surprise under [Tyson's] lopsided crown and chinchilla cloak, King said he was reminded "of Homer's Odysseus returning to Ithaca to gather his dissembled fiefdoms." Sighs Tyson: "It's tough being the youngest anything." --TIME, June...
...tell you my story,” he says. Americans always want to tell their story. His is fairly dull: wife left him, has a grown daughter, wants more children. “In order to do that, I need to find a woman who’s still of childbearing age—in her thirties. I’ve tried mail order bride services, but mine ran off on me. Can you help...
While taking Saddam down may demoralize his followers, it would not necessarily dull the anger of these other parties. In fact, many Iraqis believe it would provoke them to stronger action. "Saddam's being caught or killed isn't good for the Americans," says Marouf Sami Noori, brother-in-law of fugitive Taha Yassin Ramadan, Saddam's Vice President. "There are many people who would like to fight against the Americans, but if they fight now, they'll be considered Saddam's people. So the resistance will be stronger if Saddam is captured or killed...
...promise of blowout growth to steady profits. Shares of both companies dropped sharply. Biotech's allure since the benchmark Genentech ipo 23 years ago has been its promise to deliver wonder drugs that will cure feared ailments like cancer and Alzheimer's; compared to that, budgetary discipline seems pretty dull. Yet with an exhaustingly long list of failed products and failed companies in its brief past, the biotech industry each year grows closer to losing sway with the moneymen who fund its research. Even though biotech stocks have been moving up this year, among critical pre-ipo investors like venture...
...Books: A Dull Brick Lane